New molecular entity. Onglyza.
- Published in:
- 2009
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2009 AND VI 44 AND IP 9
Results: 14
1
2
Golimumab: a human anti-TNF-alpha monoclonal antibody for the treatment of autoimmune joint diseases.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
P&T considerations in fashioning a knowledge base, action plan for cardiometabolic disorders and weight.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
4
Editor's letter.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
5
Gastrointestinal disorders.
- Published in:
- 2009
- Publication type:
- Product Review
6
P&T considerations in fashioning a knowledge base, action plan for cardiometabolic disorders and weight.
- Published in:
- Formulary, 2009, v. 44, n. 9, p. 276
- By:
- Publication type:
- Article
7
Global health concerns generate new therapies for home and abroad.
- Published in:
- Formulary, 2009, v. 44, n. 9, p. 274
- By:
- Publication type:
- Article
8
Golimumab: A human anti-TNF-alpha monoclonal antibody for the treatment of autoimmune joint diseases.
- Published in:
- Formulary, 2009, v. 44, n. 9, p. 264
- By:
- Publication type:
- Article
9
New formulation.
- Published in:
- 2009
- Publication type:
- Product Review
10
FDA actions in brief.
- Published in:
- Formulary, 2009, v. 44, n. 9, p. 262
- Publication type:
- Article
11
New indication.
- Published in:
- 2009
- Publication type:
- Product Review
12
New molecular entity.
- Published in:
- 2009
- Publication type:
- Product Review
13
Pipeline preview.
- Published in:
- Formulary, 2009, v. 44, n. 9, p. 261
- Publication type:
- Article
14
Editor's Letter.
- Published in:
- 2009
- By:
- Publication type:
- Web Site Review